Dr. Hawkins’ 25+ year career in healthcare has included business, academic innovation and entrepreneurship. Dr. Hawkins was previously Director of the Human Genome Project for the US.DOE, and held senior executive roles at Siemens Healthcare, Philips, GE Healthcare and Amersham.
Prof. von Haeseler is Head of CIBIV (Center for Integrative Bioinformatics Vienna), at the Max Perutz Labs where he also served as the scientific director. In 2015, von Haeseler was elected as a corresponding member of the mathematics and science class of the Austrian Academy of Sciences
Prof. Wieland is an elected Member of the Academia Europea and the National Academy of Sciences, Leopoldina, as well as an Honorary member of the Charité, and is a Senior Professor for Biochemistry at Heidelberg University. Prof. Wieland's main areas of research are Enzymology, Glycobiology and Molecular Membrane Biology, including the specificity of lipid-protein interactions
Prof. Rothman is a highly distinguished biochemist and Sterling Professor of Cell Biology at Yale University who was awarded the 2013 Nobel Prize in Physiology/ Medicine. Prof. Rothman concurrently, among other positions, serves as Chairman of the Yale School of Medicine’s Department of Cell Biology and is the Director and founder of the Nanobiology Institute on Yale’s new West Campus
Dr. Lutz is an experienced biotech entrepreneur who has spent the last 15 years in leading several Life Sciences companies until a successful Exit. Before he was recently appointed as CEO/Managing Director of HepaRegeniX, he built and led LifeCodexx as the leading cffDNA-based NIPT provider from inception to reimbursement in several European countries. Michael holds a Ph.D in Bioorganic Chemistry from the ETH Zurich (Switzerland)